Literature DB >> 11158459

Comprehensive mutation screening in a cystic fibrosis center.

J J Wine1, E Kuo, G Hurlock, R B Moss.   

Abstract

OBJECTIVES AND
BACKGROUND: The identities of a cystic fibrosis (CF) patient's CFTR mutations can influence therapeutic strategies, but because >800 CFTR mutations exist, cost-effective, comprehensive screening requires a multistage approach. Single-strand conformation polymorphism and heteroduplex analysis (SSCP/HA) can be an important part of mutation detection, but must be calibrated within each laboratory. The sensitivity of a combined commercial-SSCP/HA approach to genotyping in a large, ethnically diverse US center CF population has not been established. STUDY
DESIGN: We screened all 27 CFTR exons in 10 human participants who had an unequivocal CF diagnosis including a positive sweat chloride test and at least 1 unknown allele after commercial testing for the 70 most common mutations by SSCP/HA. These participants were compared with 7 participants who had negative sweat tests but at least 1 other CF-like symptom meriting complete genotyping.
RESULTS: For the 10 CF participants, we detected 11 of 16 unknown alleles (69%) and all 4 of the known alleles (100%), for an overall rate of 75% inpatients not fully genotyped by conventional 70 mutation screen. For 7 participants with negative sweat tests, we confirmed 1 identified mutation in 14 alleles and detected 3 additional mutations. Mutations detected in both groups included 7 missense mutations (S13F, P67L, G98R, S492F, G970D, L1093P, N1303K) and 9 deletion, frameshift, nonsense or splicing mutations (R75X, G542X, DeltaF508, 451-458Delta8 bp, 5T, 663DeltaT, exon 13 frameshift, 1261+1G-->A and 3272-26A-->G). Three of these mutations were novel (G970D, L1093P, and 451-458Delta8 bp(1)). Thirteen other changes were detected, including the novel changes 1812-3 ins T, 4096-278 ins T, 4096-265 ins TG, and 4096-180 T-->G.
CONCLUSION: When combined with the 70 mutation Genzyme test, SSCP/HA analysis allows for detection of >95% of the mutations in an ethnically heterogeneous CF center population. We discuss 5 possible explanations that could account for the few remaining undetected mutations.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11158459     DOI: 10.1542/peds.107.2.280

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  7 in total

1.  Genetic screening using the colour change of a PNA-DNA hybrid-binding cyanine dye.

Authors:  L Marcus Wilhelmsson; Bengt Nordén; Kaushik Mukherjee; Maria T Dulay; Richard N Zare
Journal:  Nucleic Acids Res       Date:  2002-01-15       Impact factor: 16.971

2.  CFTR transcription defects in pancreatic sufficient cystic fibrosis patients with only one mutation in the coding region of CFTR.

Authors:  Molly B Sheridan; Timothy W Hefferon; Nulang Wang; Christian Merlo; Carlos Milla; Drucy Borowitz; Eric D Green; Peter J Mogayzel; Garry R Cutting
Journal:  J Med Genet       Date:  2010-11-20       Impact factor: 6.318

3.  Phenotypic and genetic characterization of patients with features of "nonclassic" forms of cystic fibrosis.

Authors:  Joshua D Groman; Barbara Karczeski; Molly Sheridan; Terry E Robinson; M Daniele Fallin; Garry R Cutting
Journal:  J Pediatr       Date:  2005-05       Impact factor: 4.406

4.  Direct interaction with filamins modulates the stability and plasma membrane expression of CFTR.

Authors:  William R Thelin; Yun Chen; Martina Gentzsch; Silvia M Kreda; Jennifer L Sallee; Cameron O Scarlett; Christoph H Borchers; Ken Jacobson; M Jackson Stutts; Sharon L Milgram
Journal:  J Clin Invest       Date:  2007-01-18       Impact factor: 14.808

Review 5.  Diagnosis of cystic fibrosis.

Authors:  Karen Z Voter; Clement L Ren
Journal:  Clin Rev Allergy Immunol       Date:  2008-12       Impact factor: 8.667

6.  p.G970D is the most frequent CFTR mutation in Chinese patients with cystic fibrosis.

Authors:  Xinlun Tian; Yaping Liu; Jun Yang; Han Wang; Tao Liu; Wenbing Xu; Xue Li; Yuanjue Zhu; Kai-Feng Xu; Xue Zhang
Journal:  Hum Genome Var       Date:  2016-01-07

7.  Differences in gene mutations between Chinese and Caucasian cystic fibrosis patients.

Authors:  Baoying Zheng; Ling Cao
Journal:  Pediatr Pulmonol       Date:  2016-10-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.